NEOS News and Press, Neos Therapeutics Inc. From 10/21/20

Are These At The Top Of Your Watch List This Week? Penny stocks remain one of the high points in the stock market today. After a huge breakout yesterday from WEI and previous to that, KXIN, there’s definitely a fervor for small-cap stocks right now. But there are more tha...

DALLAS and FORT WORTH, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Offic...

Neos Therapeutics, Inc. (NEOS) Q2 2020 Earnings Conference Call August 10, 2020 8:30 AM ET Company Participants Richard Eisenstadt - Chief Financial Officer Jerry McLaughlin - Chief Executive Officer Conference Call Participants Louise Chen - Cantor Roy Buchanan - JMP Secur...

Neos Therapeutics (NASDAQ: NEOS ) : Q2 GAAP EPS of -$0.11 beats by $0.02 . More news on: Neos Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

DALLAS and FORT WORTH, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it will report its second quarter 2020 financial resul...

Neos Therapeutics' ( NEOS ) share price has crashed as a result of the pandemic, but contrary to most other pharma companies, its share price hasn't recovered: The main reasons for the share price collapse are the pandemic and unusually low wholesale inventory levels, producing declines in s...

DALLAS and FORT WORTH, Texas, June 16, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Office...

DALLAS and FORT WORTH, Texas, May 26, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer...

Neos Therapeutics, Inc. (NEOS) Q1 2020 Earnings Conference Call May 11, 2020, 05:00 PM ET Company Participants Richard Eisenstadt - Chief Financial Officer Jerry McLaughlin - Chief Executive Officer Conference Call Participants Presentation Operator Thank you for hold...

Neos Therapeutics (NASDAQ: NEOS ): Q1 GAAP EPS of -$0.16 misses by $0.07 . Revenue of $14.49M (-1.0% Y/Y) misses by $0.23M . Press Release More news on: Neos Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,